Tysabri 150 mg solution for injection in pre-filled syringe

*
Pharmacy Only: Prescription
  • Company:

    Biogen Idec Ltd
  • Status:

    No Recent Update
  • Legal Category:

    Product subject to medical prescription which may be renewed (B)
  • Active Ingredient(s):

    *Additional information is available within the SPC or upon request to the company

Updated on 15 June 2022

File name

SmPC-150mg pdf.pdf

Reasons for updating

  • Change to section 4.6 - Pregnancy and lactation
  • Change to section 5.1 - Pharmacodynamic properties

Legal category:Product subject to medical prescription which may be renewed (B)

Updated on 06 April 2022

File name

Tysabri 150mg SmPC IE-NI.pdf

Reasons for updating

  • Change to section 4.2 - Posology and method of administration
  • Change to section 5.1 - Pharmacodynamic properties
  • Change to section 5.2 - Pharmacokinetic properties
  • Change to section 10 - Date of revision of the text

Legal category:Product subject to medical prescription which may be renewed (B)

Updated on 06 April 2022

File name

m1-3-1-SPC-clean-150mg-NOVA.pdf

Reasons for updating

  • Change to section 4.2 - Posology and method of administration
  • Change to section 5.1 - Pharmacodynamic properties
  • Change to section 5.2 - Pharmacokinetic properties
  • Change to section 10 - Date of revision of the text

Legal category:Product subject to medical prescription which may be renewed (B)

Updated on 02 September 2021

File name

Tysabri 150 mg solution for injection in pre-filled syringe _PIL_Aug 2021.pdf

Reasons for updating

  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 4 - possible side effects
  • Change to date of revision

Updated on 02 September 2021

File name

Tysabri 150 mg solution for injection in pre-filled syringe_SmPC_Aug 2021.pdf

Reasons for updating

  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.6 - Pregnancy and lactation
  • Change to section 4.8 - Undesirable effects
  • Change to section 9 - Date of first authorisation/renewal of the authorisation
  • Change to section 10 - Date of revision of the text

Legal category:Product subject to medical prescription which may be renewed (B)

EDM Updated on 01 July 2021

File name

TYSABRI_Physician Information Document_June 2021.pdf

Reasons for updating

  • Replace File

EDM Updated on 01 July 2021

File name

TYSABRI_Continuation_Form_June 2021.pdf

Reasons for updating

  • Replace File

EDM Updated on 01 July 2021

File name

TYSABRI_Discontinuation_Form_June 2021.pdf

Reasons for updating

  • Replace File

EDM Updated on 01 July 2021

File name

TYSABRI_Patient Alert Card_June 2021.pdf

Reasons for updating

  • Replace File

EDM Updated on 01 July 2021

File name

TYSABRI_Initiation_Form_June 2021.pdf

Reasons for updating

  • Replace File

EDM Updated on 07 June 2021

File name

Tysabri Patient Alert Card_2021.pdf

Reasons for updating

  • Add New Doc

EDM Updated on 07 June 2021

File name

Tysabri Patient Discontinuation form_2021.pdf

Reasons for updating

  • Add New Doc

EDM Updated on 07 June 2021

File name

Tysabri Patient Continuation form_2021.pdf

Reasons for updating

  • Add New Doc

EDM Updated on 07 June 2021

File name

Tysabri Patient Initiation form_2021.pdf

Reasons for updating

  • Add New Doc

EDM Updated on 07 June 2021

File name

Tysabri_Physician Information Document_2021.pdf

Reasons for updating

  • Add New Doc

Updated on 15 April 2021

File name

Tysabri 150 mg mg solution for injection in pre-filled syringe PIL.pdf

Reasons for updating

  • New PIL for new product

Updated on 15 April 2021

File name

Tysabri 150 mg solution for injection in pre-filled syringe.pdf

Reasons for updating

  • New SPC for new product

Legal category:Product subject to medical prescription which may be renewed (B)